FEMA Awards Funds to Massachusetts for COVID School Testing Costs

Print Story | Email Story
BOSTON — The Federal Emergency Management Agency will be sending more than $64 million to the Commonwealth of Massachusetts to reimburse it for the cost of contracting to provide testing services in public schools during the COVID-19 pandemic.
 
The $64,144,440 Public Assistance grant will reimburse the Massachusetts Executive Office of Health and Human Services for the cost of contracting to provide testing at schools and in public buildings in surrounding communities between February 2021 and June 2022.
 
The contractor provided services which included operations and logistics of pooled testing, training, software, and technical assistance to school personnel.
 
The contractor also provided transportation for a total of 907,829 COVID-19 test specimens from approximately 2,400 public schools across the Commonwealth of Massachusetts to the laboratory for analysis.
 
"FEMA is pleased to be able to assist Massachusetts with these costs," said FEMA Region 1 Regional Administrator Lori Ehrlich. "Reimbursing state, county, and municipal governments – as well as eligible non-profits and tribal entities – for the costs incurred during the COVID-19 pandemic is an important part of our nation's ongoing recovery."
 
FEMA's Public Assistance program is an essential source of funding for states and communities recovering from a federally declared disaster or emergency.
 
So far, FEMA has provided more than $2.7 billion in Public Assistance grants to Massachusetts to reimburse the commonwealth for pandemic-related expenses.
 

Tags: FEMA,   

If you would like to contribute information on this article, contact us at info@iberkshires.com.

Kratom Products Pulled From Pittsfield, Statewide Shelves

By Brittany PolitoiBerkshires.com Staff

PITTSFIELD, Mass.— The state has put an emergency yearlong order on kratom products, and Pittsfield is working with retailers to remove the product from shelves. 

Last week, Director of Public Health Andy Cambi delivered an update on the emergency order that went into effect on August 28.  Also known by its chemical name and marketed with the term "7-OH," Massachusetts temporarily designated kratom as a Schedule I drug, greatly restricting sales. 

The formerly unregulated product has resulted in emergency room visits, poison control calls, and deaths.  

"Dependency and the opioid-like withdrawal symptoms are the major key health concerns," Cambi explained. "Liver toxicity, seizures, just a greater overdose risk when combined with other substances, and then the main thing is that this is not regulated."

He said that throughout the years, retail shops have reached out to the Health Department looking for guidance on kratom products and were notified that it is unregulated. 

"And for the most part, when they hear that, they don't sell the product," he added. 

Kratom is a leafy plant native to Southeast Asia containing naturally occurring substances, including mitragynine and 7-hydroxymitragynine (7-OH).  It is marketed to relieve pain and can produce stimulating or sedating effects, depending on the amount taken and potency. Newer products contain highly concentrated or laboratory-modified compounds that can have significantly stronger opioid-like effects. 

Kratom products have been widely sold in smoke shops, convenience stores, and gas stations as powders, tablets, capsules, gummies, dissolvable strips, and in other forms.

View Full Story

More Pittsfield Stories